R.PR
REGISTERED-PRINCIPAL REGISTER
03/15/2022
Back to search
Official data from USPTO
FAX PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
05/04/2023
Trademark type
Word
Nice classes
42
Filing date
01/28/2020
Registration date
03/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/15/2022
Last transaction
05/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/19/2019
First use in commerce
08/19/2019
Drawing code
4
Owner type
03
Owner location
Miami, FL, US
Examiner
JACKSON, STEVEN W
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Fax Pharma Inc.
Representatives
Erik Lichter Erik Lichter
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific researchconducting clinical trials for others; Medical laboratory services; Medical research; Medical research services in the field of cancer; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Quality evaluation services for the medical and anesthesia industries; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific investigations for medical purposes; Scientific research; Scientific research and development
Publications
History of USPTO decisions and trademark events.
40 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/08/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/07/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/20/2022
DPCC
DIVISIONAL PROCESSING COMPLETE
01/20/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2022
IUAF
USE AMENDMENT FILED
12/22/2021
DRRR
DIVISIONAL REQUEST RECEIVED
12/22/2021
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
12/22/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/22/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
07/02/2021
APET
ASSIGNED TO PETITION STAFF
07/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/22/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/27/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/27/2021
PUBO
PUBLISHED FOR OPPOSITION
04/27/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/07/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/18/2021
ALIE
ASSIGNED TO LIE
03/17/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/08/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/08/2021
GNFR
FINAL REFUSAL E-MAILED
03/08/2021
CNFR
FINAL REFUSAL WRITTEN
03/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2021
ALIE
ASSIGNED TO LIE
02/18/2021
NREV
NOTICE OF REVIVAL - E-MAILED
11/25/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2020
PETG
PETITION TO REVIVE-GRANTED
11/25/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
11/25/2020
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
11/16/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
11/16/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2020
GNRT
NON-FINAL ACTION E-MAILED
04/23/2020
CNRT
NON-FINAL ACTION WRITTEN
04/23/2020
DOCK
ASSIGNED TO EXAMINER
04/16/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/03/2020
NWAP
NEW APPLICATION ENTERED
01/31/2020
Continuous trademark protection
Get notified about every new filing that threatens FAX PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.